{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T06:03:51Z","timestamp":1768284231708,"version":"3.49.0"},"reference-count":36,"publisher":"Japan Atherosclerosis Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT"],"published-print":{"date-parts":[[2012]]},"DOI":"10.5551\/jat.9589","type":"journal-article","created":{"date-parts":[[2012,8,8]],"date-time":"2012-08-08T22:42:50Z","timestamp":1344465770000},"page":"962-969","source":"Crossref","is-referenced-by-count":6,"title":["Nicotine Modulation of Factor VII Activating Protease (FSAP) Expression in Human Monocytes"],"prefix":"10.5551","volume":"19","author":[{"given":"Mariana S","family":"Parahuleva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Langanke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"H^|^ouml;lschermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Behnoush","family":"Parviz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaser","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siegbert","family":"Stracke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"Tillmanns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandip M.","family":"Kanse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Sandset PM, Hoibraaten E, Eilertsen AL, Dahm A: Mechanisms of thrombosis related to hormone therapy. Thromb Res, 2009; 123: 70-73","DOI":"10.1016\/S0049-3848(09)70015-5"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-008-0049-2"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Roy S: Effects of smoking on prostacyclin formation and platelet aggregation in users of oral contraceptives. Am J Obstet Gynecol, 1999; 180: 364-368","DOI":"10.1016\/S0002-9378(99)70697-6"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Hölschermann H, Terhalle HM, Zakel U, Maus U, Parviz B, Tillmanns H, Haberbosch W: Monocyte tissue factor expression is enhanced in women who smoke and use oral contraceptives. Thromb Haemost, 1999; 82: 1614-1620","DOI":"10.1055\/s-0037-1614888"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.110.209577"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Ouyang P, Michos ED, Karas RH: Hormone replacement therapy and the cardiovascular system lessons learned and unanswered questions. J Am Coll Cardiol, 2006; 47: 1741-1753","DOI":"10.1016\/j.jacc.2005.10.076"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Shufelt CL, Bairey Merz CN: Contraceptive hormone use and cardiovascular disease. J Am Coll Cardiol, 2009; 53: 221-231","DOI":"10.1016\/j.jacc.2008.09.042"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, Newby LK, Piña IL, Roger VL, Shaw LJ, Zhao D, Beckie TM, Bushnell C, D'Armiento J, Kris-Etherton PM, Fang J, Ganiats TG, Gomes AS, Gracia CR, Haan CK, Jackson EA, Judelson DR, Kelepouris E, Lavie CJ, Moore A, Nussmeier NA, Ofili E, Oparil S, Ouyang P, Pinn VW, Sherif K, Smith SC Jr, Sopko G, Chandra-Strobos N, Urbina EM, Vaccarino V, Wenger NK; American Heart Association: Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association. J Am Coll Cardiol, 2011; 57: 1404-1423","DOI":"10.1161\/CIR.0b013e31820faaf8"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Pellegrini PM, Newby DE, Maxwell S, Webb DJ: Short-term effects of transdermal nicotine on acute tissue plasminogen activator release in vivo in man. Cardiovasc Res, 2001; 52: 321-327","DOI":"10.1016\/S0008-6363(01)00381-9"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Zidovetzki R, Chen P, Fisher M, Hofman MF, Faraci MF: Nicotine increases plasminogen activator inhibitor-1 production by human brain endothelial cells via protein kinase C-associated pathway. Stroke, 1999; 30: 651-655","DOI":"10.1161\/01.STR.30.3.651"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Römisch J, Feussner A, Vermöhlen S, Stöhr HA: A protease isolated from human plasma activating Factor VII independent of tissue factor. Blood Coagul Fibrinolysis, 1999; 10: 471-479","DOI":"10.1097\/00001721-199912000-00004"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1097\/00001721-199912000-00004"},{"key":"13","doi-asserted-by":"crossref","unstructured":"12) Römisch J, Vermöhlen S, Feussner A, Stöhr HA: The FVII activating protease cleaves single-chain plasminogen activators. Haemostasis, 1999; 29: 292-299","DOI":"10.1159\/000022515"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1159\/000022515"},{"key":"15","doi-asserted-by":"crossref","unstructured":"13) Parahuleva MS, Kanse SM, Parviz B, Barth A, Tillmanns H, Bohle RM, Sedding DG, Hölschermann H: Factor Seven Activating Protease (FSAP) expression in human monocytes and accumulation in unstable coronary atherosclerotic plaques. Atherosclerosis, 2008; 196: 164-171","DOI":"10.1016\/j.atherosclerosis.2007.03.042"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2007.03.042"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20052546"},{"key":"18","doi-asserted-by":"crossref","unstructured":"14) Sedding D, Daniel JM, Muhl L, Hersemeyer K, Brunsch H, Kemkes-Matthes B, Braun-Dullaeus RC, Tillmanns H, Weimer T, Preissner KT, Kanse SM: The G534E polymorphism of the gene encoding the factor VII-activating protease is associated with cardiovascular risk due to increased neointima formation. J Exp Med, 2006; 203: 2801-2807","DOI":"10.1084\/jem.20052546"},{"key":"19","doi-asserted-by":"crossref","unstructured":"15) Kanse SM, Declerck PJ, Ruf W, Broze G, Etscheid M: Factor VII-Activating Protease Promotes the Proteolysis and Inhibition of Tissue Factor Pathway Inhibitor. Arterioscler Thromb Vasc Biol, 2012; 32: 427-433","DOI":"10.1161\/ATVBAHA.111.238394"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.111.238394"},{"key":"21","doi-asserted-by":"crossref","unstructured":"16) Willeit J, Kiechl S, Weimer T, Mair A, Santer P, Wiedermann CJ, Roemisch J: Marburg I polymorphism of factor VII.activating protease: a prominent risk predictor of carotid stenosis. Circulation, 2003; 107: 667-670","DOI":"10.1161\/01.CIR.0000055189.18831.B1"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000055189.18831.B1"},{"key":"23","doi-asserted-by":"crossref","unstructured":"17) Hoppe B, Tolou F, Radtke H, Kiesewtter H, Dörner T, Salama A: Marburg I polymorphism of factor VII-activating protease is associated with idiopathic venous thromboembolism. Blood, 2005; 105: 1549-1551","DOI":"10.1182\/blood-2004-08-3328"},{"key":"24","doi-asserted-by":"crossref","unstructured":"18) Sidelmann JJ, Vitzthum F, Funding E, Münster AM, Gram J, Jespersen J: Factor VII-activating protease in patients with acute deep venous thrombosis. Thromb Res, 2008; 122: 848-853","DOI":"10.1016\/j.thromres.2008.02.002"},{"key":"25","doi-asserted-by":"crossref","unstructured":"19) Ireland H, Miller GJ, Webb KE, Cooper JA, Humphries SE: The factor VII-activating protease G511E (Marburg) variant and cardiovascular risk. Thromb Haemost, 2004; 92: 986-992","DOI":"10.1160\/TH04-05-0275"},{"key":"26","doi-asserted-by":"crossref","unstructured":"20) Parahuleva MS, Hölschermann H, Erdogan A, Langanke E, Prickartz I, Parviz B, Weiskirchen R, Tillmanns H, Kanse SM: Factor seven activating protease (FSAP) levels during normal pregnancy and in women using oral contraceptives. Thromb Res, 2010; 126: 36-40","DOI":"10.1016\/j.thromres.2010.03.003"},{"key":"27","doi-asserted-by":"crossref","unstructured":"21) Sidelmann JJ, Skouby SO, Vitzthum F, Schwarz H, Jespersen J: Hormone therapy affects plasma measures of factor VII-activating protease in younger postmenopausal women. Climacteric, 2010; 13: 340-346","DOI":"10.3109\/13697131003597027"},{"key":"28","doi-asserted-by":"crossref","unstructured":"22) Reiner AP, Lange LA, Smith NL, Zakai NA, Cushman M, Folsom AR: Common hemostasis and inflammation gene variants and venous thrombosis in older adults from the Cardiovascular Health Study. J Thromb Haemost, 2009; 7: 1499-1505","DOI":"10.1111\/j.1538-7836.2009.03522.x"},{"key":"29","doi-asserted-by":"crossref","unstructured":"23) Kannemeier C, Al-Fakhri N, Preissner KT, Kanse SM: Factor VII activating protease (FSAP) inhibits growth factor-mediated cell proliferation and migration of vascular smooth muscle cells. FASEB J, 2004; 18: 728-730","DOI":"10.1096\/fj.03-0898fje"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.109.200451"},{"key":"31","doi-asserted-by":"crossref","unstructured":"25) Roemisch J, Feussner A, Stoehr HA: Quantitation of the factor VII- and single-chain plasminogen activator-activating protease in plasmas of healthy subjects. Blood Coagul Fibrinolysis, 2001; 12: 375-383","DOI":"10.1097\/00001721-200107000-00007"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1097\/00001721-200107000-00007"},{"key":"33","doi-asserted-by":"crossref","unstructured":"26) Stephan S, Schwarz H, Borchert A, Bussfeld D, Quak E, Simshaeuser-Knaub B, Teigelkamp S, Behrens F, Vitzthum F: Tests for the measurement of factor VII-activating protease (FSAP) activity and antigen levels in citrated plasma, their correlation to PCR testing, and utility for the detection of the Marburg I-polymorphism of FSAP. Clin Chem Lab Med, 2008; 46: 1109-1116","DOI":"10.1515\/CCLM.2008.218"},{"key":"34","doi-asserted-by":"publisher","DOI":"10.1038\/nature01339"},{"key":"35","doi-asserted-by":"crossref","unstructured":"28) Russel MAH, Jarvis MJ, Iyer R, Feyerabend C: Relations of nicotine yield of cigarettes to blood nicotine concentrations in smokers. Br Med J, 1980; 280: 972-975","DOI":"10.1136\/bmj.280.6219.972"},{"key":"36","doi-asserted-by":"crossref","unstructured":"29) Benowitz, NL: Pharmacological aspects of cigarette smoking and nicotine addiction. N Engl J Med, 1988; 319: 1318-1330","DOI":"10.1056\/NEJM198811173192005"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T18:46:00Z","timestamp":1621536360000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/19\/11\/19_9589\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.9589","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}